Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-01-27 @ 5:13 AM
Study NCT ID:
NCT02605304
Status:
TERMINATED
Last Update Posted:
2018-05-02
First Post:
2015-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Sponsor:
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Organization: